Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
Study NCT ID:
NCT05662332
Status:
COMPLETED
Last Update Posted:
2025-08-06
First Post:
2022-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-15
First Submit QC Date:
None
Study First Post Date:
2022-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-19
Results First Submit QC Date:
None
Results First Post Date:
2025-08-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-19
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL